Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:biotechnology
|
| gptkbp:acquired_by |
gptkb:Vertex_Pharmaceuticals
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:focus |
gptkb:gene_therapy
|
| gptkbp:founded |
gptkb:2016
|
| gptkbp:founder |
gptkb:Eric_Olson
|
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Exonics Therapeutics
|
| gptkbp:mission |
develop transformative therapies
|
| gptkbp:partnership |
Duchenne muscular dystrophy research
|
| gptkbp:targets |
gptkb:muscular_dystrophy
|
| gptkbp:technology |
CRISPR gene editing
|
| gptkbp:bfsParent |
gptkb:Vertex_Pharmaceuticals
|
| gptkbp:bfsLayer |
4
|